U.S. Gas Utilities Stock News

NYSE:BBU
NYSE:BBUIndustrials

A Look At Brookfield Business Partners (NYSE:BBU) Valuation After Softer Q1 Earnings And Recent Share Price Pullback

Q1 earnings and dividend decision put Brookfield Business Partners (NYSE:BBU) in focus Brookfield Business Partners (NYSE:BBU) is drawing attention after Brookfield Business Corporation reported first quarter 2026 results with lower sales and net income, alongside a fresh quarterly dividend declaration. For the quarter ended March 31, 2026, Brookfield Business Corporation reported sales of US$6,436 million, compared with US$6,749 million a year earlier, and net income of US$40 million,...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 Guidance - Learn Why

In early May 2026, IRADIMED CORPORATION reported first-quarter results showing sales of US$21.98 million and net income of US$5.82 million, alongside board approval of a regular US$0.20 per-share quarterly dividend payable on May 29, 2026 to shareholders of record on May 15, 2026. The company also issued earnings guidance for the second quarter and reaffirmed full-year 2026 revenue and GAAP diluted EPS targets, underscoring management’s confidence in its operating outlook. We’ll now...
NYSE:KRG
NYSE:KRGRetail REITs

What Kite Realty Group Trust (KRG)'s 2026 EPS Guidance After Softer Q1 Results Means For Shareholders

Kite Realty Group Trust reported past first-quarter 2026 results with sales of US$198.04 million and net income of US$11.39 million, alongside lower earnings per share than a year earlier. Alongside these softer year-on-year figures, management issued full-year 2026 earnings guidance of US$0.33 to US$0.39 per diluted share, offering fresh insight into expected profitability. We’ll now examine how this updated 2026 earnings guidance reshapes Kite Realty Group Trust’s existing investment...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

Why NewAmsterdam Pharma (NAMS) Is Up 29.7% After Detailing Obicetrapib Phase 3 And Launch Milestones

NewAmsterdam Pharma Company N.V. has reported first-quarter 2026 results, posting US$3.04 million in sales and a net loss of US$48.44 million, while outlining ongoing Phase 3 programs for its lead drug obicetrapib. Investors also heard that an interim analysis of the PREVAIL cardiovascular outcomes trial is planned for late 2026, alongside pending European regulatory decisions and potential initial commercial launches of obicetrapib by Menarini. We will now examine how the planned PREVAIL...
NYSE:IP
NYSE:IPPackaging

International Paper (IP) Is Up 5.9% After Returning To Profitability Amid Margin Pressures Has The Bull Case Changed?

In the past quarter ended March 31, 2026, International Paper reported sales of US$5,971 million, net income of US$60 million, and earnings per share of US$0.11, reversing losses from a year earlier. Despite this return to profitability, management highlighted that margins remain under pressure from inflation, higher energy costs, and transformation-related expenses amid softer packaging demand in key regions. Next, we will examine how International Paper’s return to profitability but...
NYSE:OPLN
NYSE:OPLNCommercial Services

A Look At OPENLANE (OPLN) Valuation After Strong Q1 Results And Upgraded 2026 Earnings Guidance

OPENLANE (OPLN) drew fresh attention after reporting first quarter 2026 results with higher revenue and net income than a year earlier, and raising full year earnings guidance. Analysts responded by increasing their estimates. See our latest analysis for OPENLANE. The raised guidance and stronger first quarter appear to have contributed to momentum, with a 30 day share price return of 27.62% and a year to date share price return of 29.72%. The 3 year total shareholder return of 151.76% points...
NYSE:STEL
NYSE:STELBanks

Assessing Stellar Bancorp (STEL) Valuation After Earnings-Driven Growth In Net Interest Income And Net Income

Stellar Bancorp’s latest earnings snapshot Stellar Bancorp (STEL) recently reported first quarter results, highlighting net interest income of US$105.93 million and net income of US$26.97 million compared with the same period last year, drawing fresh attention to the stock. See our latest analysis for Stellar Bancorp. At a share price of US$37.46, Stellar Bancorp has delivered a year to date share price return of 21.78% and a 1 year total shareholder return of 40.98%. However, the 90 day...
NasdaqGS:ADEA
NasdaqGS:ADEASoftware

Adeia (ADEA) Is Down 12.2% After Strong Q1, New Blue-Chip Deals And ESOP Shelf Filing

Adeia Inc. recently reported first-quarter 2026 results, with sales of US$104.77 million and net income of US$22.77 million, while also reiterating full-year guidance, declaring a US$0.05 dividend, and filing a US$293.39 million shelf registration for 10,700,000 common shares tied to its ESOP. Alongside these announcements, Adeia unveiled new multi-year licensing deals with major partners such as AMD, Microsoft, and L’Oréal, highlighting how its media and semiconductor intellectual property...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Assessing Vericel (VCEL) Valuation After Recent Share Price Weakness And Contrasting Growth Narratives

Recent performance snapshot Vericel (VCEL) has drawn attention after a period where the stock declined about 5% over the past month and about 6% over the past 3 months, with shares recently closing at US$33.46. See our latest analysis for Vericel. Looking beyond the recent pullback, Vericel’s 1 day and 7 day share price returns of about 5% and 8% lower, combined with a 1 year total shareholder return down 22%, suggest momentum has been fading rather than building. If you are comparing Vericel...
NasdaqGS:REYN
NasdaqGS:REYNHousehold Products

Why Reynolds Consumer Products (REYN) Is Up 5.7% After Strong Q1 Earnings And Reaffirmed 2026 Outlook

In early May 2026, Reynolds Consumer Products Inc. reported past first-quarter 2026 results showing sales and revenue of US$877 million, net income of US$59 million, and basic and diluted earnings per share of US$0.28 from continuing operations, while also issuing guidance for the second quarter and reiterating its full-year 2026 outlook. The company’s combination of higher quarterly earnings, maintained full-year targets, and a continued quarterly cash dividend of US$0.23 per share...